Alternative, diet-based approach to treating brain cancer Boston University biologists have identified an alternative, diet-based approach to treating brain tumor that will not involve administering toxic chemicals, invasive or radiation surgery. The biologists discovered that KetoCal, a commercially available high-fat, low-carbohydrate diet made to deal with epilepsy in children, can reduce the growth of brain tumors in laboratory mice significantly sildenafil . Moreover, the dietary plan significantly enhanced health insurance and survival rates relative to mice in control groups who consumed a standard low-fat, high-carbohydrate diet.
Fater. We believe our drug development platform provides significant advantages over the medication development process currently in use, which targets the time – and cost-intensive tests of compounds on nerve receptors and genes. Additionally, as these peptides and proteins are occurring in mammals naturally, there is a big probability of non-toxicity; toxicity is usually a significant issue in the current testing process, Mr. Fater concluded.. Modified state physiology drug development platform to treat a range of human conditions David H. Fater, CEO of Vicor Technologies, Inc. , announced that on July 23 today, 2009, the Australian Patent Workplace issued it a Deed of Letters Patent because of its altered condition physiology drug development platform.